Surgical Quality Improvement

Prostatectomy Outcomes

Prostatectomy ACS NSQIP Outcomes

January 1, 2024 – December 31, 2024

The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s prostatectomy ACS NSQIP performance benchmarked against 119 participating sites.

Prostatectomy (119 Sites)NObservedExpected
30 Day Morbidity1546.49%6.03%
Deep Vein Thrombosis (DVT) / Pulmonary Embolus1540.00%0.58%
Renal Failure1541.30%0.50%
Urinary Tract Infection (UTI)1542.60%2.56%
Surgical Site Infection (SSI)1541.95%2.14%
Sepsis1540.00%0.28%
Unplanned Reoperation1540.65%0.56%
Unplanned Readmission1547.79%3.45%
Rectal Injury1540.00%0.31%
Prolonged NPO/NGT Use1541.30%0.45%
Ureteral Obstruction1540.00%0.12%
Urinary Leak/Fistula1540.00%0.80%
Lymphocele/Leak/Fluid1541.95%1.55%

American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.